It is impossible to talk about structural issues in China’s IP regime and its impact upon foreigners without addressing the lack of a comprehensive approach to “bad faith” activities in all its […]
The Good Faith Elephant in the IP Trade War
Trade and Peace on Earth: Part 2
In the first part of this blog, I talked about unilateral steps that the United States and China have been taking during the ‘trade war’ to address concerns regarding forced tech transfer. […]
Trade and Peace on Earth: Part 1
O ye who read this truthful rime From Flanders, kneel and say: God speed the time when every day Shall be as Christmas Day. (Frederick Niven, “A Carol from Flanders”, regarding the […]
SO MANY CHINA IP CONFERENCES, SO LITTLE TIME…
Here’s a rundown of some past events, and some upcoming ones. I will provide an update on some of the legal developments at a later date (I know I have been a […]
Draft of Data Exclusivity Rules Released by CFDA
CFDA just released on April 25, 2018, its Public Comment Draft of Pharmaceutical Data Exclusivity Implementing Rules (provisional) 药品试验数据保护实施办法（暂行）征求意见稿, available here (the web version is here). Comments are due by May 31, 2018, […]
April 3 – 9, 2018 Updates
1.China pushes generics over brands with another round of new pharma policies. The General Office of the State Council on April 3rd, 2018 issued “The Opinion on Reforming and Improving Supply and Use […]
January 16 – 29, 2018 Update
Jan 16 – 29, 2018 Here are some updates on IP developments in China from past two weeks. China criticizes US moves on intellectual property 商务部:缺少确凿证据无可信度 China on Thursday criticized recent moves […]
December 2017 Update
Here are some updates on IP developments in China from this past December 2017: 1. Xi Jinping: China must accelerate implementation of big data strategy (English) 习近平：实施国家大数据战略加快建设数字中国 (Chinese). Xi Jinping, during a collective study […]
Three Laws/Policies Up For Public Comment
Three IP-related laws and policies have been released for public comment in the past week, at two different stages in the legislative process. The first and perhaps most significant is the revisions […]
Of Trade Secrets, Section 337, AUCL Reform and Evidence Production
When faced with trade secret misappropriation, the United States International Trade Commission can provide a forum for U.S. companies faced with unfair competition resulting from the misappropriation, even if the “theft” occurs […]
China IPR - Intellectual Property Developments in China 